Highlights
- Market Cap
- $6.81B
- Enterprise Value
- $6.51B
- EPS (TTM)
- -$4.56
- Total Revenue (TTM)
- $51.17M
- Gross Profit (TTM)
- -$111.30M
- EBITDA (TTM)
- -$323.66M
- Year Range
- $33.19 - $97.14
- Target Price
- $96.22
- ROA (TTM)
- -43.38%
- ROE (TTM)
- -50.62%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Merus N.V., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Merus N.V.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -2.64% | 15.02% | -10.62% | 8.13% | 23.20% | -6.19% | 25.93% | -0.60% | 43.00% | 0.75% | 1.35% | -6.39% | 114.03% |
| 2024 | 29.75% | 35.87% | -7.12% | -0.27% | 18.55% | 11.14% | -10.36% | -3.87% | -2.02% | -0.06% | -10.19% | -6.22% | 52.91% |
| 2023 | 0.84% | 22.24% | -3.51% | 4.24% | 13.24% | 21.22% | -0.34% | -14.75% | 5.41% | -14.72% | 23.02% | 11.16% | 77.76% |
| 2022 | -22.61% | 14.14% | -5.87% | -22.84% | -9.02% | 21.98% | 6.80% | -2.07% | -15.41% | 2.35% | -25.12% | 0.78% | -51.35% |
| 2021 | 56.99% | -18.24% | -7.16% | 0.24% | 1.00% | -0.38% | -18.37% | 51.63% | -15.64% | 27.50% | -7.27% | 22.26% | 81.40% |
| 2020 | 16.12% | 3.36% | -28.40% | 22.64% | -8.02% | 17.88% | -14.92% | -11.83% | -0.58% | 1.50% | 40.64% | 2.34% | 24.50% |
Benchmark Metrics
Merus N.V. has an annualized alpha of 37.83%, beta of 0.95, and R² of 0.06 versus S&P 500 Index. Calculated based on daily prices since May 20, 2016.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (81.70%) than losses (4.88%) — typical of diversified or defensive assets.
- R² of 0.06 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 37.83%
- Beta
- 0.95
- R²
- 0.06
- Upside Capture
- 81.70%
- Downside Capture
- 4.88%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Merus N.V. (MRUS) and compare them to a chosen benchmark (S&P 500 Index).
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Merus N.V.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Merus N.V. was 67.42%, occurring on Apr 3, 2020. Recovery took 435 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.42% | Mar 7, 2017 | 776 | Apr 3, 2020 | 435 | Dec 23, 2021 | 1211 |
| -60.36% | Dec 31, 2021 | 244 | Dec 19, 2022 | 263 | Jan 8, 2024 | 507 |
| -42.04% | Jun 28, 2024 | 195 | Apr 8, 2025 | 38 | Jun 3, 2025 | 233 |
| -26.33% | Oct 25, 2016 | 38 | Dec 16, 2016 | 3 | Dec 21, 2016 | 41 |
| -25.44% | May 26, 2016 | 2 | May 27, 2016 | 43 | Jul 29, 2016 | 45 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Merus N.V. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Merus N.V. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MRUS relative to other companies in the Biotechnology industry. Currently, MRUS has a P/S ratio of 129.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MRUS in comparison with other companies in the Biotechnology industry. Currently, MRUS has a P/B value of 10.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |